Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

4 structures for Q6P1K2

Entry ID Method Resolution Chain Position Source
5LSJ X-ray 325 A B/E 31-205 PDB
5LSK X-ray 350 A B 31-205 PDB
8Q5H EM 450 A B 1-205 PDB
AF-Q6P1K2-F1 Predicted AlphaFoldDB

192 variants for Q6P1K2

Variant ID(s) Position Change Description Diseaes Association Provenance
CA1155777
rs777939436
2 A>D No ClinGen
ExAC
gnomAD
CA1155778
rs749848175
3 E>G No ClinGen
ExAC
gnomAD
rs767498512
CA31035159
4 A>E No ClinGen
TOPMed
gnomAD
rs146867902
CA1155779
4 A>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs767498512
CA342831754
4 A>V No ClinGen
TOPMed
gnomAD
rs1474510250
CA342831803
6 S>G No ClinGen
TOPMed
rs778448047
CA1155782
6 S>I No ClinGen
ExAC
TOPMed
gnomAD
rs778448047
CA1155780
6 S>N No ClinGen
ExAC
TOPMed
gnomAD
rs778448047
CA1155781
6 S>T No ClinGen
ExAC
TOPMed
gnomAD
rs775216061
CA1155783
8 N>H No ClinGen
ExAC
TOPMed
gnomAD
CA342831873
rs1382705777
8 N>K No ClinGen
gnomAD
CA1155784
rs746586716
11 S>G No ClinGen
ExAC
gnomAD
rs1353582802
CA342831923
11 S>N No ClinGen
gnomAD
CA342831932
rs1414253839
11 S>R No ClinGen
gnomAD
rs1558186229
CA342831954
12 G>A No ClinGen
Ensembl
CA1155785
rs768555004
12 G>C No ClinGen
ExAC
TOPMed
gnomAD
CA342831978
rs1237224129
13 C>F No ClinGen
TOPMed
gnomAD
rs377730230
CA1155786
13 C>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs201504927
CA1155787
13 C>W No ClinGen
ExAC
gnomAD
CA342831972
rs1237224129
13 C>Y No ClinGen
TOPMed
gnomAD
rs201900663
CA31035222
14 E>G No ClinGen
gnomAD
CA1155789
rs773234191
15 E>G No ClinGen
ExAC
gnomAD
rs1001667083
CA31035248
17 R>T No ClinGen
Ensembl
CA342832108
rs1256304903
18 H>P No ClinGen
gnomAD
rs1370706308
CA342832117
19 E>K No ClinGen
TOPMed
CA342832163
rs1449576325
20 G>E No ClinGen
TOPMed
CA1155792
rs752974319
20 G>R No ClinGen
ExAC
TOPMed
gnomAD
rs1572471692
CA342832189
21 S>A No ClinGen
Ensembl
rs764581905
CA1155794
21 S>L No ClinGen
ExAC
TOPMed
gnomAD
rs995807995
CA31035276
22 S>F No ClinGen
Ensembl
CA1155797
rs146208639
24 E>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1155798
rs746310331
25 S>P No ClinGen
ExAC
gnomAD
CA31035329
rs765440844
26 V>M No ClinGen
Ensembl
rs1389889375
CA342832324
27 P>L No ClinGen
TOPMed
gnomAD
CA342832311
rs1381486325
27 P>S No ClinGen
gnomAD
CA342832314
rs1381486325
27 P>T No ClinGen
gnomAD
rs779418661
CA1155801
28 P>H No ClinGen
ExAC
TOPMed
gnomAD
rs779418661
CA1155800
28 P>R No ClinGen
ExAC
TOPMed
gnomAD
rs757941220
CA1155799
28 P>T No ClinGen
ExAC
gnomAD
CA1155803
rs776537237
29 G>C No ClinGen
ExAC
gnomAD
CA1155804
rs200909305
29 G>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA342832374
rs1212275118
30 T>A No ClinGen
gnomAD
CA342832409
rs1483980342
31 T>I No ClinGen
gnomAD
rs769670305
CA1155805
32 I>S No ClinGen
ExAC
gnomAD
CA342832438
rs1201769847
33 S>A No ClinGen
TOPMed
rs773285630
CA1155806
37 L>F No ClinGen
ExAC
TOPMed
gnomAD
CA31035426
rs758510947
38 L>F No ClinGen
Ensembl
rs762922221
CA1155807
40 T>I No ClinGen
ExAC
gnomAD
rs1345305369
CA342832571
41 M>K No ClinGen
TOPMed
rs1176793557
CA342832580
42 V>L No ClinGen
gnomAD
CA1155810
rs767691638
45 F>S No ClinGen
ExAC
gnomAD
rs772185695 45 F>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
CA1155811
rs775423643
46 L>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA342832642
rs1324263311
47 Q>K No ClinGen
gnomAD
CA1155813
rs564773343
48 K>Q No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA342832670
rs1304069342
49 L>V No ClinGen
gnomAD
rs377154093
CA1155816
52 A>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs377154093
CA1155817
52 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs750988132
CA1155818
53 G>S No ClinGen
ExAC
TOPMed
rs758828671
CA1155819
54 S>N No ClinGen
ExAC
gnomAD
CA342836923
rs1386414799
56 Q>E No ClinGen
gnomAD
TCGA novel 56 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1155883
rs756934419
58 F>L No ClinGen
ExAC
gnomAD
rs1042744406
CA31050158
60 D>G No ClinGen
TOPMed
CA1155884
rs764982739
61 C>F No ClinGen
ExAC
gnomAD
CA31050163
rs764982739
61 C>Y No ClinGen
ExAC
gnomAD
rs1333096573
CA342837025
62 Y>C No ClinGen
gnomAD
CA1155886
rs147468189
65 F>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs756196951
CA1155890
71 A>G No ClinGen
ExAC
TOPMed
gnomAD
CA1155889
rs756196951
71 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA1155891
rs749539268
72 M>I No ClinGen
ExAC
gnomAD
CA342837218
rs1425372371
72 M>K No ClinGen
TOPMed
gnomAD
CA342837220
rs1425372371
72 M>T No ClinGen
TOPMed
gnomAD
rs945773581
CA31050254
73 T>A No ClinGen
Ensembl
CA342837242
rs1190784458
74 Q>* No ClinGen
TOPMed
CA1155893
rs1052053
75 Q>P No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA1155892
rs1052053
VAR_034147
75 Q>R No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA342837284
rs1258650400
77 Y>C No ClinGen
gnomAD
rs1407001469
CA342837298
78 D>A No ClinGen
gnomAD
CA342837348
rs1339850190
81 I>M No ClinGen
TOPMed
gnomAD
rs907005503
CA31050258
82 A>V No ClinGen
Ensembl
rs1400721909
CA342837374
84 L>M No ClinGen
gnomAD
CA342837391
rs1280293649
85 Q>* No ClinGen
gnomAD
CA342837419
rs532329234
87 S>F No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs772522149
CA1155895
87 S>P No ClinGen
ExAC
gnomAD
CA1155896
rs532329234
87 S>Y No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs773324194
CA1155898
89 R>Q No ClinGen
ExAC
gnomAD
rs150630684
CA1155897
89 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA342837447
rs1465617335
90 E>D No ClinGen
gnomAD
rs1558196153
CA342837449
91 E>K No ClinGen
Ensembl
CA342837477
rs1303591719
94 D>E No ClinGen
gnomAD
rs762578734
CA1155920
95 I>V No ClinGen
ExAC
gnomAD
rs1572502384
CA342837485
96 K>E No ClinGen
Ensembl
CA1155922
rs149817565
99 G>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1155924
rs767507954
100 N>Y No ClinGen
ExAC
gnomAD
CA31051287
rs971132932
101 L>V No ClinGen
TOPMed
CA31051294
rs752534455
COSM897142
102 E>* Variant assessed as Somatic; impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA1155925
rs752534455
102 E>Q No ClinGen
ExAC
TOPMed
gnomAD
CA31051298
rs11548876
103 A>V No ClinGen
Ensembl
CA342837539
rs1309885401
104 V>A No ClinGen
gnomAD
rs757360180
CA1155926
107 A>S No ClinGen
ExAC
gnomAD
TCGA novel 110 K>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA342837605
rs1200001096
114 E>K No ClinGen
Ensembl
CA342837617
rs1196437202
115 G>A No ClinGen
gnomAD
rs1196437202
CA342837618
115 G>V No ClinGen
gnomAD
rs750744751
CA1155928
116 K>E No ClinGen
ExAC
gnomAD
rs758667378
CA1155929
118 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs141326392
CA1155930
118 R>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs369423554
CA1155933
120 E>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs377059409
CA1155932
120 E>K No ClinGen
ESP
ExAC
gnomAD
rs748544819
CA1155934
122 A>T No ClinGen
ExAC
gnomAD
rs771971437
CA1155959
COSM675670
124 R>C lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA342839397
rs1487327435
124 R>H No ClinGen
gnomAD
rs1229804115
CA342839414
125 P>S No ClinGen
TOPMed
CA342839434
rs1264057676
126 S>T No ClinGen
gnomAD
CA1155962
rs766235404
127 G>R No ClinGen
ExAC
TOPMed
gnomAD
rs1006626784
CA31053363
128 I>F No ClinGen
TOPMed
rs1405159530
CA342839484
129 P>A No ClinGen
TOPMed
gnomAD
rs1163067794
CA342839494
129 P>L No ClinGen
TOPMed
gnomAD
rs1405159530
CA342839481
129 P>T No ClinGen
TOPMed
gnomAD
CA342839510
rs1167465484
130 E>G No ClinGen
gnomAD
rs763130134
CA1155964
131 K>E No ClinGen
ExAC
TOPMed
gnomAD
CA342839564
rs1297012800
132 D>E No ClinGen
gnomAD
CA1155965
rs766510624
132 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs1044925132
CA31053378
134 H>Y No ClinGen
TOPMed
CA1155966
rs751868897
135 S>G No ClinGen
ExAC
TOPMed
gnomAD
CA342839594
rs751868897
135 S>R No ClinGen
ExAC
TOPMed
gnomAD
CA342839608
rs1558197641
136 V>I No ClinGen
Ensembl
CA1155969
rs1052067
VAR_034148
137 M>I No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs767964139
CA1155968
137 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA1155967
rs146023155
137 M>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA1155970
rs555212220
138 A>V No ClinGen
1000Genomes
ExAC
gnomAD
rs778280527
CA1155971
140 Y>D No ClinGen
ExAC
gnomAD
rs1239408709
CA342839701
143 Q>* No ClinGen
TOPMed
gnomAD
CA31053416
rs1031004715
144 Q>H No ClinGen
TOPMed
gnomAD
CA1155972
rs573328595
144 Q>K No ClinGen
1000Genomes
ExAC
gnomAD
CA1155974
rs778285141
145 R>Q No ClinGen
ExAC
gnomAD
CA1155973
rs149553436
145 R>W No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs62001898
CA1155977
149 R>Q No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA1155976
rs140410413
149 R>W No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs62001899
CA1155978
150 R>C No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs768500887
CA1155979
150 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs371184439
CA1155980
151 H>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1329327337
CA342839917
153 Q>H No ClinGen
TOPMed
TCGA novel 154 K>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1331747405
CA342839921
154 K>Q No ClinGen
gnomAD
CA31053465
rs374332989
154 K>R No ClinGen
ESP
TOPMed
rs1410082687
CA342839936
155 Q>* No ClinGen
TOPMed
CA1155981
rs761830699
156 E>G No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 157 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA1155985
rs767655347
158 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA342839987
rs1445871536
158 E>V No ClinGen
gnomAD
CA1155986
rs148649401
159 N>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs761027917
CA1155987
160 Q>* No ClinGen
ExAC
TOPMed
gnomAD
CA1155988
rs764380670
160 Q>R No ClinGen
ExAC
gnomAD
COSM463146
CA342840055
rs1205873320
165 A>V kidney [Cosmic] No ClinGen
cosmic curated
gnomAD
rs141293459
CA1155991
166 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1170275332
CA342840094
170 R>Q No ClinGen
gnomAD
CA1155993
rs548726372
170 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
CA1155995
rs367865962
172 Q>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1572506653
CA342840119
173 V>G No ClinGen
Ensembl
CA342840114
rs1178149427
173 V>M No ClinGen
gnomAD
rs1572506659
CA342840128
174 E>G No ClinGen
Ensembl
rs370310915
CA1155998
175 E>D No ClinGen
ESP
ExAC
gnomAD
rs1233377219
CA342840149
177 Q>* No ClinGen
TOPMed
CA1155999
rs769830916
178 L>I No ClinGen
ExAC
gnomAD
CA342840165
rs1331904881
179 Q>* No ClinGen
gnomAD
CA1156000
rs773153057
179 Q>R No ClinGen
ExAC
gnomAD
CA342840171
rs180708431
180 V>F No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1572506730
CA342840175
180 V>G No ClinGen
Ensembl
rs180708431
CA1156001
180 V>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs772118740
CA1156002
181 Q>* No ClinGen
ExAC
gnomAD
rs528319714
CA1156003
182 A>G No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA1156005
rs764484778
184 Q>H No ClinGen
ExAC
gnomAD
CA31053570
rs1030430623
184 Q>P No ClinGen
TOPMed
gnomAD
rs754182108
CA1156006
185 Q>* No ClinGen
ExAC
rs917756111
CA31053582
188 Q>* No ClinGen
TOPMed
CA31001575
rs202060317
189 A>P No ClinGen
gnomAD
CA342816151
rs202060317
189 A>T No ClinGen
gnomAD
CA31001588
rs769669279
193 E>A No ClinGen
TOPMed
gnomAD
rs747282929
CA1156025
193 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs1374510120
CA342816260
194 Q>R No ClinGen
gnomAD
TCGA novel 195 R>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs768891606
CA1156026
199 A>T No ClinGen
ExAC
gnomAD
CA31001606
rs984804277
200 V>M No ClinGen
Ensembl
rs551755441
CA1156027
201 L>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs570064124
CA1156028
202 R>K No ClinGen
1000Genomes
ExAC
gnomAD
CA31001625
rs1045059204
203 E>D No ClinGen
TOPMed
gnomAD
rs765580235
CA1156029
204 P>A No ClinGen
ExAC
TOPMed
gnomAD
CA1156030
rs765580235
204 P>S No ClinGen
ExAC
TOPMed
gnomAD
CA1156032
rs765849095
205 E>D No ClinGen
ExAC
gnomAD
CA1156031
rs763512993
205 E>K No ClinGen
ExAC
TOPMed
gnomAD

No associated diseases with Q6P1K2

3 regional properties for Q6P1K2

Type Name Position InterPro Accession
binding_site Peptidase M16, zinc-binding site 88 - 111 IPR001431
domain Peptidase M16, C-terminal 220 - 404 IPR007863
domain Peptidase M16, N-terminal 68 - 214 IPR011765

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Chromosome, centromere, kinetochore
  • Associated with the kinetochore
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

9 GO annotations of cellular component

Name Definition
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
Golgi apparatus A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways.
intracellular membrane-bounded organelle Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.
kinetochore A multisubunit complex that is located at the centromeric region of DNA and provides an attachment point for the spindle microtubules.
MIS12/MIND type complex A multiprotein kinetochore subcomplex that binds to centromeric chromatin and forms part of the inner kinetochore. It helps to recruit outer kinetochore subunits that will bind to microtubules. In humans, it consists of MIS12, DSN1, NSL1 and PMF1.
NMS complex A supercomplex formed by the association of two subcomplexes (known as MIND and Ndc80 in Schizosaccharomyces) with additional proteins at the kinetochores of condensed nuclear chromosomes.
nuclear MIS12/MIND complex A multiprotein kinetochore subcomplex that binds to centromeric chromatin and forms part of the inner kinetochore of a chromosome in the nucleus. It helps to recruit outer kinetochore subunits that will bind to microtubules. Nuclear localization arises in some organisms because the nuclear envelope is not broken down during mitosis. In S. cerevisiae, it consists of at least four proteins: Mtw1p, Nnf1p, Nsl1p, and Dsn1.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
transcription regulator complex A protein complex that is capable of associating with DNA by direct binding, or via other DNA-binding proteins or complexes, and regulating transcription.

2 GO annotations of molecular function

Name Definition
leucine zipper domain binding Binding to a leucine zipper domain, a protein secondary structure exhibiting a periodic repetition of leucine residues at every seventh position over a distance covering eight helical turns.
transcription coactivator activity A transcription coregulator activity that activates or increases the transcription of specific gene sets via binding to a DNA-bound DNA-binding transcription factor, either on its own or as part of a complex. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coactivators modifies chromatin structure through covalent modification of histones. A second class remodels the conformation of chromatin in an ATP-dependent fashion. A third class modulates interactions of DNA-bound DNA-binding transcription factors with other transcription coregulators. A fourth class of coactivator activity is the bridging of a DNA-binding transcription factor to the general (basal) transcription machinery. The Mediator complex, which bridges sequence-specific DNA binding transcription factors and RNA polymerase, is also a transcription coactivator.

4 GO annotations of biological process

Name Definition
cell cycle The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.
cell division The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells.
chromosome segregation The process in which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. In eukaryotes, chromosome segregation begins with the condensation of chromosomes, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles.
transcription by RNA polymerase II The synthesis of RNA from a DNA template by RNA polymerase II (RNAP II), originating at an RNA polymerase II promoter. Includes transcription of messenger RNA (mRNA) and certain small nuclear RNAs (snRNAs).

1 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q9CPV5 Pmf1 Polyamine-modulated factor 1 Mus musculus (Mouse) PR
10 20 30 40 50 60
MAEASSANLG SGCEEKRHEG SSSESVPPGT TISRVKLLDT MVDTFLQKLV AAGSYQRFTD
70 80 90 100 110 120
CYKCFYQLQP AMTQQIYDKF IAQLQTSIRE EISDIKEEGN LEAVLNALDK IVEEGKVRKE
130 140 150 160 170 180
PAWRPSGIPE KDLHSVMAPY FLQQRDTLRR HVQKQEAENQ QLADAVLAGR RQVEELQLQV
190 200
QAQQQAWQAL HREQRELVAV LREPE